BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18160173)

  • 1. Calcitonin-derived peptide carriers: mechanisms and application.
    Rennert R; Neundorf I; Beck-Sickinger AG
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):485-98. PubMed ID: 18160173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting cell-penetrating peptides.
    Hansen M; Kilk K; Langel U
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):572-9. PubMed ID: 18045726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein and peptide transduction, twenty years later a happy birthday.
    Prochiantz A
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):448-51. PubMed ID: 18053614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells.
    Rennert R; Neundorf I; Jahnke HG; Suchowerskyj P; Dournaud P; Robitzki A; Beck-Sickinger AG
    ChemMedChem; 2008 Feb; 3(2):241-53. PubMed ID: 18205166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural investigations of a human calcitonin-derived carrier peptide in a membrane environment by solid-state NMR.
    Wagner K; Beck-Sickinger AG; Huster D
    Biochemistry; 2004 Oct; 43(39):12459-68. PubMed ID: 15449935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane permeable peptide vectors: chemistry and functional design for the therapeutic applications.
    Futaki S
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):447. PubMed ID: 18077052
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular internalization of enhanced green fluorescent protein ligated to a human calcitonin-based carrier peptide.
    Machova Z; Mühle C; Krauss U; Tréhin R; Koch A; Merkle HP; Beck-Sickinger AG
    Chembiochem; 2002 Jul; 3(7):672-7. PubMed ID: 12325002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C; Nielsen HM
    Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chances and pitfalls of cell penetrating peptides for cellular drug delivery.
    Tréhin R; Merkle HP
    Eur J Pharm Biopharm; 2004 Sep; 58(2):209-23. PubMed ID: 15296950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel daunorubicin-carrier peptide conjugates derived from human calcitonin segments.
    Krauss U; Kratz F; Beck-Sickinger AG
    J Mol Recognit; 2003; 16(5):280-7. PubMed ID: 14523941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and application of peptides as drug carriers.
    Rennert R; Neundorf I; Beck-Sickinger AG
    Methods Mol Biol; 2009; 535():389-403. PubMed ID: 19377983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape.
    Foerg C; Ziegler U; Fernandez-Carneado J; Giralt E; Rennert R; Beck-Sickinger AG; Merkle HP
    Biochemistry; 2005 Jan; 44(1):72-81. PubMed ID: 15628847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific labeling with potent radiolabels alters the uptake of cell-penetrating peptides.
    Walther C; Ott I; Gust R; Neundorf I
    Biopolymers; 2009; 92(5):445-51. PubMed ID: 19399852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
    Meade BR; Dowdy SF
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed analysis concerning the biodistribution and metabolism of human calcitonin-derived cell-penetrating peptides.
    Neundorf I; Rennert R; Franke J; Közle I; Bergmann R
    Bioconjug Chem; 2008 Aug; 19(8):1596-603. PubMed ID: 18651757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models.
    Tréhin R; Krauss U; Beck-Sickinger AG; Merkle HP; Nielsen HM
    Pharm Res; 2004 Jul; 21(7):1248-56. PubMed ID: 15290867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in cell-penetrating, non-peptide molecular carriers.
    Chung SK; Maiti KK; Lee WS
    Int J Pharm; 2008 Apr; 354(1-2):16-22. PubMed ID: 17890027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin-derived carrier peptides.
    Neundorf I; Beck-Sickinger AG
    Curr Pharm Des; 2005; 11(28):3661-9. PubMed ID: 16305502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and rapid cytosolic delivery using cell-penetrating peptides mediated by pyrenebutyrate.
    Takeuchi T; Kosuge M; Tadokoro A; Sugiura Y; Nishi M; Kawata M; Sakai N; Matile S; Futaki S
    ACS Chem Biol; 2006 Jun; 1(5):299-303. PubMed ID: 17163758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intracellular and nuclear-targeted delivery of an antiandrogen drug by carrier peptides.
    Hodoniczky J; Sims CG; Best WM; Bentel JM; Wilce JA
    Biopolymers; 2008; 90(5):595-603. PubMed ID: 18351583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.